Home > News > An Opportunity for Harris & Harris?
March 14th, 2007
An Opportunity for Harris & Harris?
Though I'm not advising you to jump on the bandwagon and start investing willy-nilly in unprofitable IPOs, one company could ulimately profit from this trend: Motley Fool Rule Breakers recommendation Harris & Harris (Nasdaq: TINY).
As a publicly traded venture capital firm, the company has most of its money invested in small private nanotech start-ups, including Molecular Imprint, Nantero, and Nanosys (among many others). And while I have no indication that any of these companies are, in fact, planning to go public, today's more risk-tolerant environment bodes well for the prospect that they might.
Nanometrics to Announce First Quarter Financial Results on April 29, 2014 April 9th, 2014
Harris & Harris Group Notes Mersana's Collaboration Agreement With Subsidiary of Takeda Pharmaceutical Co. April 8th, 2014
Harris & Harris Group Continues Its Blog Series to Highlight Most Impactful Portfolio Companies With Metabolon, Inc. April 7th, 2014
Graphene industry takes further step towards commercialisation with Haydale IPO listing March 19th, 2014
Scientists observe quantum superconductor-metal transition and superconducting glass: A team including MIPT physicist observed quantum superconductor-metal transition and superconducting glass April 16th, 2014
UT Arlington physicist creates new nanoparticle for cancer therapy April 16th, 2014
Relieving electric vehicle range anxiety with improved batteries: Lithium-sulfur batteries last longer with nanomaterial-packed cathode April 16th, 2014
Malvern reports on the publication of the 1000th peer-reviewed paper to cite NanoSight’s Nanoparticle Tracking Analysis, NTA April 16th, 2014